Brief: Idorsia Says Aprocitentan Cuts Blood Pressure Across Cardiometabolic Disease Spectrum
12/10/2026 06:06
BRIEF-Idorsia Says Aprocitentan Cuts Blood Pressure Across Cardiometabolic Disease Spectrum Oct 12 (Reuters) - Idorsia Ltd IDIA.S:
APROCITENTAN EFFICACY DATA REINFORCE ENDOTHELIN PATHWAY BLOCKADE AS A DISTINCT THERAPEUTIC APPROACH ACROSS THE CARDIOMETABOLIC DISEASE SPECTRUM INCLUDING OBESITY
IDORSIA - APROCITENTAN DECREASES UACR, MAINTAINS STABLE EGFR IN OBESITY COHORT
IDORSIA - EGFR REMAINS STABLE THROUGHOUT STUDY IN CKM COHORTS
IDORSIA - APROCITENTAN REDUCES OFFICE SYSTOLIC BLOOD PRESSURE BY 15.4-16.0 MMHG IN OBESITY AT WEEK 4
Source text: [ID:]
Further company coverage: IDIA.S
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00))